Atlas Trials

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions

Clinical trial NCT00882570 · COMPLETED

Trial details

NCT number
NCT00882570
Sponsor
Sandoz
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2005-04-01
Primary completion
2005-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.